Opportunity ID: 300714

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-17-032
Funding Opportunity Title: Funding For Collaborative Clinical Research In Type 1 Diabetes: Living Biobank (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards: 5
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 14, 2018
Last Updated Date:
Original Closing Date for Applications: Jul 10, 2018
Current Closing Date for Applications: Jul 10, 2018
Archive Date: Aug 15, 2018
Estimated Total Program Funding: $3,000,000
Award Ceiling: $600,000
Award Floor:

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Public and State controlled institutions of higher education
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
County governments
State governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
For profit organizations other than small businesses
Special district governments
Private institutions of higher education
Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) invites applications for studies of etiology and pathogenesis related to development of type 1 diabetes (T1D) and/or its complications. Studies must involve subjects enrolled and followed in clinical trials, long term follow-up, or observational studies. This opportunity is intended to fund collaborative projects that bring new expertise and innovative approaches to enhance the value of major ongoing clinical research projects.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-032.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or after January 25, 2018 PKG00238256 Jun 10, 2018 Jul 10, 2018 View

Package 1

Mandatory forms

300714 RR_SF424_2_0-2.0.pdf

300714 PHS398_CoverPageSupplement_4_0-4.0.pdf

300714 RR_OtherProjectInfo_1_4-1.4.pdf

300714 PerformanceSite_2_0-2.0.pdf

300714 RR_KeyPersonExpanded_2_0-2.0.pdf

300714 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

300714 RR_Budget_1_4-1.4.pdf

300714 RR_SubawardBudget30_1_4-1.4.pdf

300714 PHS398_ModularBudget_1_2-1.2.pdf

300714 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T10:24:24-05:00

Share This Post, Choose Your Platform!

About the Author: